Chemoinformaics analysis of 2-(2-Thienylmethylene)-1,6-dioxaspiro[4.4]non-3-ene
Molecular Weight | 220.293 | nRot | 1 |
Heavy Atom Molecular Weight | 208.197 | nRig | 16 |
Exact Molecular Weight | 220.056 | nRing | 3 |
Solubility: LogS | -3.261 | nHRing | 3 |
Solubility: LogP | 2.528 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
No. of Oxygen atom | 2 | No. of Arom Bond | 5 |
nHA | 3 | APOL | 32.5455 |
nHD | 0 | BPOL | 17.9705 |
QED | 0.723 |
Synth | 4.286 |
Natural Product Likeliness | 0.483 |
NR-PPAR-gamma | 0.711 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.007 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.362 |
MDCK | 0.0000368 |
BBB | 0.232 |
PPB | 0.95564 |
VDSS | 1.468 |
FU | 0.0302644 |
CYP1A2-inh | 0.708 |
CYP1A2-sub | 0.637 |
CYP2c19-inh | 0.921 |
CYP2c19-sub | 0.572 |
CYP2c9-inh | 0.371 |
CYP2c9-sub | 0.115 |
CYP2d6-inh | 0.924 |
CYP2d6-sub | 0.403 |
CYP3a4-inh | 0.842 |
CYP3a4-sub | 0.634 |
CL | 12.857 |
T12 | 0.301 |
hERG | 0.115 |
Ames | 0.092 |
ROA | 0.067 |
SkinSen | 0.949 |
Carcinogencity | 0.087 |
EI | 0.174 |
Respiratory | 0.932 |
NR-Aromatase | 0.503 |
Antiviral | No |
Prediction | 0.582148 |